DPP-4

nwamba # Aha ngwaahịa Nkọwa
CPDA0048 Omarigliptin Omarigliptin, nke a makwaara dị ka MK-3102, bụ onye na-egbochi DPP-4 na-eme ogologo oge maka ọgwụgwọ ụdị ọrịa shuga 2 kwa izu.
CPDA1089 Retagliptin Retagliptin, nke a makwaara dị ka SP-2086, bụ ihe mgbochi DPP-4 nwere ike iji maka ọgwụgwọ ụdị ọrịa shuga 2.
CPDA0088 Trelagliptin Trelagliptin, nke a makwaara dị ka SYR-472, bụ ihe mgbochi dipeptidyl peptidase-4 (DPP-4) na-eme ogologo oge nke Takeda na-emepụta maka ọgwụgwọ ụdị ọrịa shuga 2 (T2D).
CPDA2039 Linagliptin Linagliptin, makwaara dị ka BI-1356, bụ ihe mgbochi DPP-4 nke Boehringer Ingelheim mepụtara maka ọgwụgwọ ụdị ọrịa shuga II.
CPDA0100 Sitagliptin Sitagliptin (INN; nke amataburu dị ka MK-0431 ma ree ya n'okpuru aha azụmaahịa Januvia) bụ ọgwụ antihyperglycemic ọnụ (ọgwụ mgbochi ọrịa shuga) nke klaasị inhibitor dipeptidyl peptidase-4 (DPP-4).
nke

Kpọtụrụ anyị

Ajuju

Akụkọ kacha ọhụrụ

  • Usoro 7 kachasị na nyocha ọgwụ na 2018

    Usoro 7 kacha elu na nyocha ọgwụ m...

    N'ịbụ ndị nọ n'okpuru nrụgide na-arịwanye elu mgbe niile ịsọ mpi na gburugburu ebe obibi akụ na ụba na nkà na ụzụ siri ike, ụlọ ọrụ ọgwụ na biotech ga-anọgide na-emepe emepe na mmemme R&D ha iji nọgide na-aga n'ihu ...

  • ARS-1620: Onye mmechi ọhụrụ na-ekwe nkwa maka ọrịa cancer KRAS-mutant

    ARS-1620: ihe mgbochi ọhụrụ na-ekwe nkwa maka K…

    Dị ka otu nnyocha e bipụtara na Cell si kwuo, ndị nchọpụta ewepụtala ihe mgbochi kpọmkwem maka KRASG12C nke a na-akpọ ARS-1602 nke na-eme ka ụbụrụ tumor regression na ụmụ oke. "Ọmụmụ ihe a na-enye na vivo ihe akaebe na mutant KRAS nwere ike ịbụ ...

  • AstraZeneca na-enweta nkwalite nchịkwa maka ọgwụ oncology

    AstraZeneca na-enweta nkwalite nchịkwa maka ...

    AstraZeneca nwetara nkwalite okpukpu abụọ maka pọtụfoliyo oncology ya na Tuesday, mgbe ndị na-ahụ maka US na European nabatara ntinye iwu maka ọgwụ ya, nzọụkwụ mbụ iji nweta nkwado maka ọgwụ ndị a. ...

Mkparịta ụka WhatsApp n'ịntanetị!